+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Dasatinib-induced pulmonary arterial hypertension unresponsive to PDE-5 inhibition

Dasatinib-induced pulmonary arterial hypertension unresponsive to PDE-5 inhibition

European Respiratory Journal 42(3): 869-870

(PDF emailed within 0-6 h: $19.90)

Accession: 052448390

Download citation: RISBibTeXText

PMID: 24000257

DOI: 10.1183/09031936.00035913

Related references

Dasatinib-induced pulmonary arterial hypertension. British Journal of Clinical Pharmacology 84(5): 835-845, 2018

First histopathological evidence of irreversible pulmonary vascular disease in dasatinib-induced pulmonary arterial hypertension. European Respiratory Journal 51(3), 2018

Dasatinib-induced pulmonary arterial hypertension - A rare late complication. Journal of Oncology Pharmacy Practice 2018: 1078155217753740, 2018

Computed tomography-measured pulmonary artery to aorta ratio and EUTOS score for detecting dasatinib-induced pulmonary arterial hypertension. International Journal of Cardiovascular Imaging 2019, 2019

Dasatinib-Induced Pulmonary Arterial Hypertension Treated with Upfront Combination Therapy. Case Reports in Cardiology 2018: 3895197, 2018

Dasatinib-induced pulmonary arterial hypertension complicated with scleroderma: a case report. European Heart Journal. Case Reports 3(1): Ytz025, 2019

Long-term outcomes of dasatinib-induced pulmonary arterial hypertension: a population-based study. European Respiratory Journal 50(1), 2018

Rho-Kinase Inhibition Ameliorates Dasatinib-Induced Endothelial Dysfunction and Pulmonary Hypertension. Frontiers in Physiology 9: 537, 2018

Combination targeted pulmonary hypertension therapy in the resolution of Dasatinib-associated pulmonary arterial hypertension. Pulmonary Circulation 7(4): 803-807, 2017

Pulmonary arterial hypertension in patients treated by dasatinib. Circulation 125(17): 2128-2137, 2012

Dasatinib: pulmonary arterial hypertension. French data. Prescrire International 20(120): 241-241, 2011

Reversible dasatinib-related pulmonary arterial hypertension in a CML patient. Japanese Journal of Clinical Hematology 57(5): 618-623, 2016

Reversible Pulmonary Arterial Hypertension Associated with Dasatinib for Chronic Myeloid Leukemia. Cancer Research and Treatment 47(4): 937-942, 2017

Pulmonary arterial hypertension in a patient treated with dasatinib: a case report. Journal of Medical Case Reports 11(1): 362, 2018

Clinical features of pulmonary arterial hypertension in patients receiving dasatinib. American Journal of Hematology 90(11): 1060-1064, 2016